Lv5
1400 积分 2020-08-12 加入
Myeloproliferative Neoplasms
8天前
已完结
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN / HMA
2个月前
已完结
FLT3 mutations as diagnostic and prognostic biomarkers in acute myeloid leukemia
3个月前
已完结
Concomitant or sequential lower intensity triplet therapy in AML
4个月前
已关闭
How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission
5个月前
已完结
Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
5个月前
已完结
Acute lymphocytic leukaemia
5个月前
已完结
Early Driver, Late Bystander: Stage-Specific Roles of DNMT3A R882 Mutations Unveiled in Human AML
6个月前
已完结
Overcoming Menin inhibitor resistance in AML cells with combinations including BET proteins and dual BRG1/BRM inhibitor
6个月前
已关闭
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT
6个月前
已完结
皖公网安备34019202002308
